Research

March 31, 2022

Crowe receives national award for COVID antibody research

Vanderbilt’s James Crowe Jr., MD, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19.

By Bill Snyder
March 29, 2022

There’s no slowing arterial stiffening

Over 10 years, multiple healthy behaviors did not slow the progression of arterial stiffness, a risk factor for coronary artery disease, hypertension, stroke, atrial fibrillation and heart failure.

By Paul Govern
March 28, 2022

Rheumatoid arthritis: special deliveries

Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.

By Bill Snyder
March 24, 2022

Stress in young adult cancer patients and caregivers

Adolescent and young adult oncology patients and caregivers experience psychosocial impairment and financial toxicity at the time of cancer diagnosis, findings that will inform interventions to support patient and caregiver well-being.

By Leigh MacMillan
March 24, 2022

Reducing obesity-related inflammation

A treatment that increases levels of lipid signaling molecules reduced adipose tissue inflammation in obese adults, suggesting this pathway may be a valuable target for modulating fat and systemic inflammation.

By VUMC News and Communications
Joseph Breeyear, left, Todd Edwards, PhD, and colleagues are studying how high blood pressure genes can improve heart surgery survival in children.
March 24, 2022

High blood pressure genes improve heart surgery survival in children

Vanderbilt researchers have found that children with a genetic makeup that predicts high blood pressure as adults are more likely to survive congenital heart defect repair surgery.

By Leigh MacMillan
March 17, 2022

Blood test figures in cancer risk for people with HIV

A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer.
By Paul Govern
March 17, 2022

Discovery Lecture featuring Sánchez Alvarado returns to in-person format

Alejandro Sánchez Alvarado, PhD, executive director and chief scientific officer of the Stowers Institute for Medical Research in Kansas City, Missouri, will discuss tissue regeneration at the next Discovery Lecture, in person on Thursday, March 24 in 208 Light Hall.
By Leigh MacMillan
March 15, 2022

Improving care for gynecologic cancer

To reduce risk of deep vein thrombosis in patients being treated for gynecologic cancer, Vanderbilt researchers recommend that providers use Khorana scores and provide prophylactic treatment according to clinical guidelines.
By Emily Stembridge
March 14, 2022

Microbiome reflects COVID-19 severity

Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered.
By Elliot Jaffe 
March 10, 2022

Bots boost liver cancer outcome

Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients.
By Leah Mann 
March 10, 2022

Technique hastens COVID-19 antibody discovery

Optimization of a technique developed at Vanderbilt University Medical Center enables rapid and efficient identification of neutralizing monoclonal antibodies against the virus that causes COVID-19.
By Bill Snyder
March 10, 2022

Brain function expert Deisseroth set for March 17 Discovery Lecture

Optogenetics pioneer Karl Deisseroth, MD, PhD, will speak at Vanderbilt's upcoming Discovery Lecture on Thursday, March 17.
By Bill Snyder
1 … 22 23 24 25 26 … 56